Immunization

A table showing recommended immunization schedules for child and adolescent patients.

Two tables show recommended immunization schedules for adults.

The 2020 virtual Directions in Pharmacy® conference provided a comprehensive overview of influenza, including identifying at-risk patients and providing interventions to address vaccination misconceptions.

Moderna will manufacture doses of its experimental coronavirus disease 2019 vaccine candidate as clinical trials are ongoing to expedite the production process.

A study showed that pharmacists in the state of Wisconsin are most likely to administer zoster and influenza vaccines to customers.

This Pharmacy Times® Webcast discusses a number of topics pertaining to the pharmacists’ role in immunization practices, including the precautions and safety equipment necessary amidst the COVID-19 pandemic, pharmacy automation and operations, and best practices to navigate patient care.

The American Cancer Society is renewing efforts to increase HPV immunization as COVID-19 threatens to slow cancer prevention progress.

An expert panel of world-renowned professionals will discuss the latest details on the rapid advances in vaccine development and what they mean to clinicians on the front line.

Steven C. Anderson, FASAE, CAE, IOM, president and CEO of the National Association of Chain Drug Stores, has been invited to join the office of Health and Human Services’ new COVID-19 Vaccine Consultation Panel.

Two mRNA- based vaccine candidates are currently in development by Pfizer and BioNTech.

The human papillomavirus infection (HPV) vaccine should be administered in 2 doses for children between 9 and 12 years of age, according to updated guidelines from the American Cancer Society (ACS).

Pharmacists must be able to identify populations that are at high risk for influenza complications.

Pharmacy Times® interviewed Samir Balile, PharmD, on the safety measures Giant pharmacies are taking to protect patients and staff members upon reopening their doors, as well as the importance of the flu vaccine during COVID-19.

Results from 2 initial phase 3 studies evaluating an investigational 15-valent pneumococcal conjugate vaccine were recently released, assessing its immunogenicity, safety, and tolerability.

The medical pioneer never patented or profited from his work that saved untold numbers of lives.

Pharmacists can greatly contribute to herd immunity during this unprecedented health crisis.

In addition to adhering to the CDC recommendations, pharmacies should consider workflow changes intended to minimize risk to both patients and the pharmacy staff providing immunization services.

No matter how it all shakes out, pharmacists now have a level of responsibility they never had before.

Gardasil 9 approved for the prevention of oropharyngeal cancer and other head and neck cancers caused by human papillomavirus types 16, 18, 31, 33, 45, 52, and 58.

The COVID-19 pandemic rapidly pushed traditional face-to-face instruction within schools of pharmacy into a fully remote learning environment.

Flip the Pharmacy helps pharmacy teams provide enhanced clinical services for their patients and has developed a COVID-19 best practices program.

Although most children admitted to pediatric ICUs for COVID-19 had underlying conditions, children, teens, and young adults are at a greater risk for severe complications than researchers had previously believed.

Positive interim clinical data of the mRNA-1273 vaccine (Moderna, Inc) against the coronavirus disease 2019 were reported from a phase 1 study led by the National Institute of Allergy and Infectious Diseases.

To support the successful reopening of the country in a manner that prevents further COVID-19 outbreaks, the NACDS has issued a report in which it urges government action on 3 key objectives.

A harmonized and collaborative approach to coronavirus disease 2019 (COVID-19) vaccine research and development is necessary for a successful outcome.